<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hypothetically, K-ras mutations can be used as a marker of disseminated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells (<z:chebi fb="17" ids="53093">DTCs</z:chebi>) in patients with K-ras mutated primary <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This study focused on the development of a useful assay for detecting low numbers of <z:chebi fb="17" ids="53093">DTCs</z:chebi> in potential target tissues of metastatic K-ras codon 12 mutated <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>, liver, lymph node and bone marrow tissues from 46 colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> patients were examined for K-ras codon 12 mutations with a new double enriched nested (<z:chebi fb="9" ids="34873">DEN</z:chebi>)-PCR and the incidence of mutations was compared to those obtained from three established assays </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="9" ids="34873">DEN</z:chebi>-PCR followed by sequencing found one mutated cell within 107 K-ras codon 12 <z:mp ids='MP_0002169'>wild-type</z:mp> cells and was more sensitive than other methods (1:106-1:102) </plain></SENT>
<SENT sid="4" pm="."><plain>Colon <z:mp ids='MP_0002038'>carcinomas</z:mp> (26/46) and <z:mpath ids='MPATH_270'>adenomas</z:mpath> (1/3) harbored mutations in K-ras codon 12 </plain></SENT>
<SENT sid="5" pm="."><plain>Sixteen of these 27 mutated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were found with <z:hpo ids='HP_0000001'>all</z:hpo> assays, two with three methods and one with the two most sensitive assays </plain></SENT>
<SENT sid="6" pm="."><plain>In 8 cases, only <z:chebi fb="9" ids="34873">DEN</z:chebi>-PCR identified the K-ras mutation, and thus prevailed over the other methods used (p&lt;0.002) </plain></SENT>
<SENT sid="7" pm="."><plain>Eight of 26 patients with K-ras mutated colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> also harbored K-ras mutated <z:chebi fb="17" ids="53093">DTCs</z:chebi> in liver and lymph nodes, respectively, and 4 in bone marrow </plain></SENT>
<SENT sid="8" pm="."><plain>For liver and lymph node samples, <z:chebi fb="17" ids="53093">DTC</z:chebi>-mutations were identical to those in the primary <z:mp ids='MP_0002038'>carcinoma</z:mp> but those in bone marrow differed from the respective mutation in the primary <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, <z:chebi fb="9" ids="34873">DEN</z:chebi>-PCR is a highly sensitive method for detecting K-ras mutations as marker of early and late <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell dissemination in tissues potentially harboring colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
</text></document>